Sign In
Buy IXC
$0.120
+0 (+0%)
At Close: Nov 18, 2025
Invex Therapeutics Earnings Calls
Sep 30, 2025
| Release date | Feb 15, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Jun 30, 2025
| Release date | Aug 11, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0016 |
| Revenue estimate | - |
| Revenue actual | 229.084K |
Mar 30, 2025
| Release date | Aug 15, 2024 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Dec 31, 2024
| Release date | Feb 06, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0047 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Invex Therapeutics
Below you can see how IXC.AX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Dec 31, 2024
| Release date | Feb 06, 2025 |
| Price on release | $0.0730 |
| EPS estimate | - |
| EPS actual | -$0.0047 |
| Date | Price |
|---|---|
| Jan 31, 2025 | $0.0700 |
| Feb 03, 2025 | $0.0700 |
| Feb 04, 2025 | $0.0700 |
| Feb 05, 2025 | $0.0700 |
| Feb 06, 2025 | $0.0730 |
| Feb 07, 2025 | $0.0730 |
| Feb 10, 2025 | $0.0750 |
| Feb 11, 2025 | $0.0750 |
| Feb 12, 2025 | $0.0750 |
| 4 days before | 4.29% |
| 4 days after | 2.74% |
| On release day | 0% |
| Change in period | 7.14% |
Mar 30, 2025
| Release date | Aug 15, 2024 |
| Price on release | $0.0700 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 09, 2024 | $0.0710 |
| Aug 12, 2024 | $0.0710 |
| Aug 13, 2024 | $0.0700 |
| Aug 14, 2024 | $0.0700 |
| Aug 15, 2024 | $0.0700 |
| Aug 16, 2024 | $0.0700 |
| Aug 19, 2024 | $0.0700 |
| Aug 20, 2024 | $0.0700 |
| Aug 21, 2024 | $0.0700 |
| 4 days before | -1.41% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -1.41% |
Jun 30, 2025
| Release date | Aug 11, 2025 |
| Price on release | $0.0900 |
| EPS estimate | - |
| EPS actual | -$0.0016 |
| Date | Price |
|---|---|
| Aug 06, 2025 | $0.0920 |
| Aug 07, 2025 | $0.0920 |
| Aug 08, 2025 | $0.0900 |
| Aug 10, 2025 | $0.0900 |
| Aug 11, 2025 | $0.0900 |
| Aug 12, 2025 | $0.0900 |
| Aug 13, 2025 | $0.0750 |
| Aug 15, 2025 | $0.0750 |
| Aug 18, 2025 | $0.0950 |
| 4 days before | -2.17% |
| 4 days after | 5.56% |
| On release day | 0% |
| Change in period | 3.26% |
Sep 30, 2025
| Release date | Feb 15, 2025 |
| Price on release | $0.0750 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 10, 2025 | $0.0750 |
| Feb 11, 2025 | $0.0750 |
| Feb 12, 2025 | $0.0750 |
| Feb 13, 2025 | $0.0750 |
| Feb 14, 2025 | $0.0750 |
| Feb 17, 2025 | $0.0750 |
| Feb 18, 2025 | $0.0750 |
| Feb 19, 2025 | $0.0750 |
| Feb 20, 2025 | $0.0650 |
| 4 days before | 0% |
| 4 days after | -13.33% |
| On release day | 0% |
| Change in period | -13.33% |
Invex Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for IXC.AX?
Invex Therapeutics Ltd (IXC.AX) has scheduled its earnings report for Feb 05, 2026 before the markets open.
What is the IXC.AX price-to-earnings (P/E) ratio?
IXC.AX P/E ratio as of Nov 18, 2025 (TTM) is -18.99.
What is the IXC.AX EPS forecast?
The forecasted EPS (Earnings Per Share) for Invex Therapeutics Ltd (IXC.AX) for the first fiscal quarter 2025 is $.
What are Invex Therapeutics Ltd's retained earnings?
On its balance sheet, Invex Therapeutics Ltd reported retained earnings of $0 for the latest quarter ending Sep 30, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
